CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

News

Vaccinating girls and boys against human papillomavirus (HPV) prevents the development of several serious cancers and protects human lives
12.7.2018 Committee on Healthcare from the Chamber of Deputies of the Parliament of the Czech Republic | More information...

As in most developed European countries, a vaccination programme against HPV has also been introduced in the Czech Republic. HPV vaccines are reimbursed from the public health insurance if the first dose is administered between ages 13 and 14. Both girls and boys can be vaccinated under this scheme.

Does HPV vaccination prevent the development of cervical cancer? Are there harms associated with being vaccinated?
9.5.2018 Cochrane Press Release | More information...

New evidence published in the Cochrane Library [1] shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarises findings on harms that have been assessed in randomised controlled trials.

Vaccine to prevent most cervical cancers shows long-term effectiveness
5.9.2017 UAB Press Release | More information...

A vaccine that can literally eradicate the majority of cervical cancer cases shows long-term effectiveness in a study published in The Lancet [1].

Archive